238 related articles for article (PubMed ID: 1826874)
1. [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy].
Olivieri A; Fostini R; Xerri L; Recchia G
Clin Ter; 1991 Jan; 136(1):53-61. PubMed ID: 1826874
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolones: how to use (but not overuse) these antibiotics.
Sable CA; Scheld WM
Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
[TBL] [Abstract][Full Text] [Related]
3. Resistance situation of oral antibiotics in the Scandinavian countries with special reference to the fluoro-quinolones.
Midtvedt T
Scand J Infect Dis Suppl; 1990; 68():7-13. PubMed ID: 2218426
[TBL] [Abstract][Full Text] [Related]
4. The role of the fluoroquinolones in primary care practice.
Harding GK
Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484
[No Abstract] [Full Text] [Related]
5. Prescribing considerations in fluoroquinolone therapy.
Gentry LO
Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
[TBL] [Abstract][Full Text] [Related]
6. Quinolones for short-term treatment of uncomplicated urinary tract infection.
Kadiri S; Ajayi SO; Toki RA
East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
[TBL] [Abstract][Full Text] [Related]
7. [Urinary tract infections: risk factors and therapeutic trends].
Margariti PA; Astorri AL; Mastromarino C
Recenti Prog Med; 1997 Feb; 88(2):65-8. PubMed ID: 9148368
[TBL] [Abstract][Full Text] [Related]
8. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
9. Therapy of urinary tract infections in the elderly: role of fluoroquinolones.
Sant GR; Wainstein M
Urology; 1990 Jan; 35(1 Suppl):19-21. PubMed ID: 2404371
[No Abstract] [Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Tested and new chemotherapy in infectious diseases].
Hoigné R; Keller MF
Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
[No Abstract] [Full Text] [Related]
12. [Antibacterial therapy of complicated urinary infections in outpatients].
Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Shevelev AN
Urologiia; 2004; (5):25-31. PubMed ID: 15560157
[TBL] [Abstract][Full Text] [Related]
13. [Current antibiotics for clinical practice].
Zimmerli W
Praxis (Bern 1994); 1996 Oct; 85(40):1240-4. PubMed ID: 8966413
[TBL] [Abstract][Full Text] [Related]
14. New agents in development for the treatment of bacterial infections.
Abbanat D; Morrow B; Bush K
Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
Poletti T; Bertola D; Pellerito R; Soragna A
Minerva Med; 1980 Jul; 71(27):1935-43. PubMed ID: 6248823
[TBL] [Abstract][Full Text] [Related]
16. [Trial of use of a new oral antibiotic: cephalexin in granules in 59 children].
Bovier-Lapierre M; David M; Lauras B
Lyon Med; 1971 Dec; 226(20):895-900. PubMed ID: 5144397
[No Abstract] [Full Text] [Related]
17. [Antibiotic therapy by first intention].
Bastin R
Rev Prat; 1983 Oct; 33(45):2361-76. PubMed ID: 6648276
[No Abstract] [Full Text] [Related]
18. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
19. [Quinolones].
Lode H
Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial and anti-algal activity if two traditional drugs in the treatment of urinary tract infection and cystitis in Mali].
Rokia S; Drissa D; Seydou D; Colette E; Flabou B
Mali Med; 2006; 21(1):18-24. PubMed ID: 17390524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
